You are here

datopotamab deruxtecan

ASCO 2023 – early first-line lung cancer data mined for datopotamab gold

EP Vantage

Wed, 06/7/23 - 10:02 am

datopotamab deruxtecan

non-small cell lung cancer

The first big test for the son of Enhertu

EP Vantage

Fri, 01/20/23 - 10:17 am

datopotamab deruxtecan

clinical trials

AstraZeneca-Daiichi Sankyo’s therapy shows response in breast cancer trials

Clinical Trials Arena

Mon, 12/12/22 - 10:26 am

clinical trials

datopotamab deruxtecan

metastatic triple-negative breast cancer

Feeling Collaborative, Merck Inks Three More Deals to Strengthen Portfolio

BioSpace

Tue, 10/26/21 - 12:01 am

Xeris Biopharma

Evaxion Biotech

datopotamab deruxtecan